secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0001641172-25-013084
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics shareholders approve 30M share increase and 1-for-2.5 to 1-for-10 reverse split
--------------------------------------------------------------------------------

- Stockholders elected directors Stroever, Angle, Gagnon, and Meikle; all received >90% of votes cast (excluding broker non-votes).
- Approved plan amendment increasing authorized shares by 30M to 30,629,489 for equity awards.
- Authorized board to implement reverse stock split in range of 1-for-2.5 to 1-for-10 at its discretion.
- Ratified Weinberg & Company as auditor for FY2025; advisory say-on-pay passed with 63% support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/0001641172-25-013084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225013084/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer